T2DM and ApoE4 are recognized independent risk factors for neurodegenerative diseases, including AD, but the mechanisms by which they increase the risk of neurodegeneration remain unclear [46, 47]. This evidence concerns the gene APOE and type 2 diabetes mellitus.